NYSE$HNGE
Hinge Health Inc · Q4 2025 earnings
Q4 2025 earnings · · After market close · Investor relations
Briefing
Hinge Health reported Q4 2025, revenue of $170.7M, net income of $31.1M, diluted EPS of $0.37.
For Q4 2025, Hinge Health reported revenue of $170.7M, net income of $31.1M, diluted EPS was $0.37, adjusted diluted EPS was $0.49. Management discusses segment performance, capital allocation, and macro risks in the quarterly filing.
- Revenue $170.7M.
- Net income $31.1M.
- Diluted EPS $0.37.
- Adjusted diluted EPS $0.49.
Headline financials
Revenue & EPS history
Hinge Health, Inc. · Revenue · Quarterly
$171M
Forward guidance
The quarterly filing discusses operating priorities, capital returns, and sector risks; numeric multi-quarter bridges vary by issuer.
Tailwinds
- MD&A highlights liquidity, capital, and core business trends.
- Segment or product commentary supports the earnings narrative.
Headwinds
- Macro, rates, or input costs may pressure near-term margins.
- One-time items can affect year-over-year comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 3 quarterly earnings reports · overlaid with Q4 2025
+7.3%
Avg return
Earnings day
+9.1%
Avg return
5 days after
+15.0%
Avg return
30 days after
75%
3 / 4 earnings
Positive
+17.3%
Q4 2025
Best reaction
-1.6%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.4% | +15.3% | +29.3% | |
| Q4 2025 | +17.3% | +17.8% | +36.2% | |
| Q3 2025 | -1.6% | +2.8% | -2.5% | |
| Q2 2025 | +11.3% | +0.3% | -3.2% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro